Latest filing published 18 Jun 2010 for ALNYLAM PHARMACEUTICALS, INC., €17k.
Insider track record
No signal scores available.
James L. Vincent: trading record in brief
This profile gathers the share dealings of James L. Vincent in Alnylam Pharmaceuticals, Inc. We count 14 filings; the first trade dates from 11 June 2010 and the latest from 18 June 2010.
The open-market record consists of 8 sales worth €1.1M, with no purchase. The rest of the record consists of 6 option exercises.
The record was last updated on 18 June 2010 with an open-market sale (€17k) in Alnylam Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James L. Vincent
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,333 shares@ US$15.70Common StockSEC:0001325812-10-000025:0
- 8,667 shares@ US$15.16Common StockSEC:0001325812-10-000025:1
- 12,100 shares@ US$7.02Common StockSEC:0001325812-10-000025:2
- 12,100 shares@ US$15.19Common StockSEC:0001325812-10-000025:3
- 30,000 shares@ US$7.02Common StockSEC:0001325812-10-000023:0
- 30,000 shares@ US$16.00Common StockSEC:0001325812-10-000023:1
- 15,000 shares@ US$7.02Common StockSEC:0001325812-10-000019:0
- 15,000 shares@ US$15.95Common StockSEC:0001325812-10-000019:1
- 10,000 shares@ US$7.02Common StockSEC:0001325812-10-000019:2
- 10,000 shares@ US$16.10Common StockSEC:0001325812-10-000019:3
- 5,000 shares@ US$7.02Common StockSEC:0001325812-10-000019:4
- 5,000 shares@ US$16.10Common StockSEC:0001325812-10-000019:5
- 2,900 shares@ US$7.02Common StockSEC:0001325812-10-000019:6
- 2,900 shares@ US$16.05Common StockSEC:0001325812-10-000019:7
14 of 14 declarations
